KFDA approves Yuhan's amlodipine generic

Published: 2004-07-28 06:59:00

Updated: 2004-07-28 06:59:00

KFDA said on July 22 it has approved Yuhan Corporation's Amlopin capsule (amlodipine maleate) for the treatment of hypertension and it is the fifth approval of amlodipine generics, following Hanmi's Amodipin (amodipine camsylate), SK Pharm's Scad (amlodipine maleate), Chong Kun Dang's Anidipin (a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK